Takeda Boosts Pipeline and Revenue Growth Prospects With $1.2B Deal for Innovent Cancer Drugs

Takeda’s agreement with Innovent Biologics brings cancer drugs that could become contributors to a portfolio that’s facing the patent cliff. The pharmaceutical giant’s strategy for finding new blockbuster prospects spans internally discovered drugs and in-licensed assets. The post Takeda Boosts Pipeline and Revenue Growth Prospects With $1.2B Deal for Innovent Cancer Drugs appeared first on…

Read More

Hyro Snags $45M for Its Conversational AI Agents

Agentic AI company Hyro has now raised a total of $95 million. Its agents, which automate call center workflows, are used by health systems including Intermountain Healthcare, Bon Secours Mercy Health, Hackensack Meridian Health, Baptist Health and Sutter Health. The post Hyro Snags $45M for Its Conversational AI Agents appeared first on MedCity News.

Read More

To Help Achieve Life-Saving Discoveries, AI Must Access ‘Underutilized, Undervalued’ Findings

AI-powered platforms can collect data sets from disparate sources and check them for quality, duplication, relevance, and more. These platforms can then create even more extensive, understandable findings to help healthcare professionals make decisions.  The post To Help Achieve Life-Saving Discoveries, AI Must Access ‘Underutilized, Undervalued’ Findings appeared first on MedCity News.

Read More

From Pollen to Plate: Identifying Pollen Food Allergy Syndrome

Diagnosing PFAS can be challenging, but establishing a thorough symptom history along with specific IgE blood testing can build a fuller picture of patients’ allergic triggers and sensitizations, helping clinicians develop accurate, tailored treatment recommendations and ultimately improve their patients’ quality of life. The post From Pollen to Plate: Identifying Pollen Food Allergy Syndrome appeared…

Read More